story of the week
Effect of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
N. Engl. J. Med 2022 Aug 27;[EPub Ahead of Print], SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, AF Hernandez, SE Inzucchi, MN Kosiborod, CSP Lam, F Martinez, SJ Shah, AS Desai, PS Jhund, J Belohlavek, CE Chiang, CJW Borleffs, J Comin-Colet, D Dobreanu, J Drozdz, JC Fang, MA Alcocer-Gamba, W Al Habeeb, Y Han, JW Cabrera Honorio, SP Janssens, T Katova, M Kitakaze, B Merkely, E O'Meara, JFK Saraiva, SN Tereshchenko, J Thierer, M Vaduganathan, O Vardeny, S Verma, VN Pham, U Wilderäng, N Zaozerska, E Bachus, D Lindholm, M Petersson, AM LangkildeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.